Macy Zou

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

Danuta M. Skowronski, Yossi Febriani, Solmaz Setayeshgar et al. · Clinical Infectious Diseases · 2022 · 138 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)

Danuta M. Skowronski, Suzana Sabaiduc, Siobhan Leir et al. · Eurosurveillance · 2019 · 68 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada

Danuta M. Skowronski, Solmaz Setayeshgar, Yossi Febriani et al. · medRxiv · 2021 · 61 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada

Danuta M. Skowronski, Solmaz Setayeshgar, Macy Zou et al. · Clinical Infectious Diseases · 2021 · 54 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016–2017 and 2017–2018 Epidemics in Canada

Danuta M. Skowronski, Siobhan Leir, Suzana Sabaiduc et al. · The Journal of Infectious Diseases · 2020 · 45 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Genetics +17